ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Codiak BioSciences Inc

Codiak BioSciences Inc (CDAK)

0.057
0.00
(0.00%)
Closed September 18 4:00PM
0.057
0.00
( 0.00% )
Pre Market: 8:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.057
Bid
0.0447
Ask
0.0448
Volume
-
0.00 Day's Range 0.00
0.057 52 Week Range 0.057
Previous Close
0.057
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CDAK Latest News

Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process

CAMBRIDGE, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics...

Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics...

Codiak Presents Preclinical Data on exoASO™-STAT6 and exoASO™-C/EBPβ Programs at the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting

– exoASO-STAT6 demonstrated durable pharmacokinetic/pharmacodynamic profile in preclinical models; biomarkers with clinical translational potential identified, providing a rationale for selecting...

Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress

– Patient enrollment continuing in Phase 1 clinical trial of exoASO™-STAT6 in patients with advanced hepatocellular carcinoma; preliminary data anticipated during 1H 2023 – – Presented preclinical...

Codiak Presents Preclinical Data Demonstrating its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants of SARS-CoV-2 and Related Sarbecoviruses

– Data support advancement of Codiak’s engineered exosome bivalent vaccine candidate toward IND-enabling studies – CAMBRIDGE, Mass., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc...

Codiak to Present New Preclinical Data Demonstrating Potent Monotherapy Activity of Two Engineered Exosome Intravenous Candidates Targeting Macrophages

– Data to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting – CAMBRIDGE, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK), a...

Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based...

Codiak Announces Proposed Public Offering of Common Stock and Warrants

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based...

Codiak BioSciences Announces Program Reprioritization and Corporate Restructuring

– Enrollment continues in Phase 1 clinical trial of IV-administered exoASO™-STAT6 in patients with advanced hepatocellular carcinoma –                   – Prioritizing vaccine program funded by...

Codiak BioSciences Reports Second Quarter 2022 Financial Results and Operational Progress

– Reported platform-validating initial data from Phase 1 studies of exoSTING™ and exoIL-12™; plans to initiate Phase 2 studies for both programs in 1H 2023 – – Initiated patient dosing in Phase 1...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0570.0570.05700CS
4000.0570.0570.05700CS
12000.0570.0570.05700CS
26000.0570.0570.05700CS
52000.0570.0570.05700CS
156-18.993-99.700787401619.0519.610.05321987341.56769128CS
260-14.043-99.595744680914.137.850.05321966405.29311167CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZEOZeo Energy Corporation
$ 4.10
(259.65%)
3.04M
XCURExicure Inc
$ 6.39
(179.04%)
3M
TBIOTelesis Bio Inc
$ 3.29
(141.91%)
3.92M
VEROVenus Concept Inc
$ 0.82
(63.18%)
3.13M
FRGTFreight Technologies Inc
$ 0.178
(43.66%)
24.55M
BNRBurning Rock Biotech Ltd
$ 1.51
(-56.66%)
1
PGNYProgyny Inc
$ 17.90
(-26.76%)
63.27k
ATMCAlphaTime Acquisition Corporation
$ 9.00
(-19.64%)
10
CUTRCutera Inc
$ 0.64
(-16.05%)
13
VEEAVeea Inc
$ 10.32
(-15.76%)
36.88k
FRGTFreight Technologies Inc
$ 0.178
(43.66%)
24.55M
MAXNMaxeon Solar Technologies Ltd
$ 0.1078
(18.59%)
10.76M
VMARVision Marine Technologies Inc
$ 0.8647
(43.40%)
4.02M
TBIOTelesis Bio Inc
$ 3.29
(141.91%)
3.92M
VEROVenus Concept Inc
$ 0.82
(63.18%)
3.13M

Discussion

View Full Feed
jackson73 jackson73 3 minutes ago
TBIO 4.30 sweet
TBIO
jackson73 jackson73 3 minutes ago
TBIO 4.00+
TBIO
Bountiful_Harvest Bountiful_Harvest 4 minutes ago
Inflation 2.0

https://pbs.twimg.com/media/GX0n3SOakAIJnBB?format=jpg&name=4096x4096
AG
TechandBio TechandBio 4 minutes ago
non invasive platforms in medical field doing amazing things PLSE ICCM
ICCM PLSE
Princess17 Princess17 5 minutes ago
India took delivery of 47 mil oz
SLV
Smitty5150 Smitty5150 5 minutes ago
I have no idea who Fireman is, but my question still has not be answered with a definitive answer that is based on facts ( I dont like speculation) = Why hasn't NW started the evidence package for NICE? Why wasn't this being worked on well before the ASM? Linda Powers stated herself the work has be
ASM
Just the facts maam Just the facts maam 5 minutes ago
Sr Convertible Notes may start getting converted when ANIP trades at or above $96.34 for 20 consecutive days after September 30, 2024. The following is from ANIP's filing.

Generally. Subject to ?Section 5.01(C)(ii), a Note may be Converted only in the following circumstances:
ANIP
TrendTrade2016 TrendTrade2016 6 minutes ago
NOT MUCH FUN UNLESS YOU OWN IT...GREAT SHORT TRADE COMING UP
OMEX
TechandBio TechandBio 6 minutes ago
$SMMT was a dollar ICCM is .69 kills cancers across many indications including breast and lung cancers no side effects no IV no pills a platform that kills cancer by freezing it multiple studies done independently with 5 year data with 97% success rate 5 years out.
https://www.prnewswire.com/
ICCM SMMT
jackson73 jackson73 7 minutes ago
VMAR .86 ww
VMAR
GetSeriousOK GetSeriousOK 9 minutes ago
An insider, or someone who did some DD.

Here it is straight from the horse's mouth: "The final rule will be issued in early November."
https://www.cms.gov/newsroom/fact-sheets/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center
BIEL
100lbStriper 100lbStriper 10 minutes ago
$NLST You can watch the Senate Judiciary Committee hearing today at 10 am ET through this link below. FYI, there is more on the agenda than the two IP bills.

https://www.judiciary.senate.gov/committee-activity/hearings/09/19/2024/executive-business-meeting-1

AGENDA
NLST
Invest-in-America Invest-in-America 10 minutes ago
But, was HE paid?? And YOU were paid, naturally. Well then, GOD BLESS the both of you!!! (And we'll leave it at that.)
XCUR
jackson73 jackson73 11 minutes ago
TBIO 3.50 ww room to go...


525k floater
TBIO
Not likely Not likely 12 minutes ago
And s/h's wanted out and it happened.

Pump a p/r then dump it.

This is static with this scam as everyone knows.

Old school playbook.


Lol with you pumpers always trying to deny the truth with this ruse.
SPZI
Invest-in-America Invest-in-America 14 minutes ago
And ZEO just landed on Jupiter, Homeboy!!! (BONKERS!!!)
ZEO
davidsson10 davidsson10 16 minutes ago
Reasons To Choose Your Recipes Wisely

https://www.cnn.com/2024/09/18/health/mind-diet-cognitive-decline-wellness/index.html

Color, texture, flavor.....
exwannabe exwannabe 18 minutes ago
Here is the path to biologic equivalence according to LP at the ASM [highlighting below is mine]. What part of no clinical trial is required don't you understand? Please explain where you get your claim that a clinical trial will be required to certify Eden for commercial production.
How do
ASM
retireat40 retireat40 18 minutes ago
The reaction so far hasn’t been overwhelming.
OMEX
wagner wagner 18 minutes ago
It would be great if intends will not be the only mentioned part of a new story,
still no volume and shortseller in charge.
Financing, loan could everything......
NB
LTListener LTListener 20 minutes ago
So many irons in the fire for sure.

Short-term (Q4) should be exciting as this is way overdue for an update on the OSA and NIH/gabakine platforms. The ampakine phase 2 SCI getting started is a big deal and I think investors would love to hear expected milestones on this trial and how
RSPI
TommyBoyTrader9460 TommyBoyTrader9460 21 minutes ago
$SHMP
https://x.com/autumnsdad1/status/1836709438578635029?s=61
SHMP
TommyBoyTrader9460 TommyBoyTrader9460 21 minutes ago
$SHMP
https://x.com/autumnsdad1/status/1836709438578635029?s=61
SHMP
StayHumble StayHumble 25 minutes ago
w0wXcellent🟩Kramers 100% Involved🟩BillionsNakedSH0rt ???

It explains the situation about shorting and naked shorting perfectly!

Again, this is a MUST WATCH video for anyone who believes in $DBMM (naked or otherwise)!

I'd love to hear
AMC BBBY CRTD
TommyBoyTrader9460 TommyBoyTrader9460 27 minutes ago
$KNOS
https://x.com/autumnsdad1/status/1836707819413774501?s=61
KNOS

Your Recent History

Delayed Upgrade Clock